StudyFinder

Research Into Visual Endpoints and RB Health Outcomes After Treatment (RIVERBOAT)

Recruiting

This is a cross-sectional, non-therapeutic study in a cohort of retinoblastoma patients. The study will estimate the prevalence of specific late effects and SMN, assess for predictors of these late effects and SMN, and identify factors predictive of these late effects and SMN, and identify factors predictive of decreased HRQoL.

I'm interested

This study is also accepting healthy volunteers

Biological Sibling, Cancer Survivor, Intraocular Retinoblastoma, Retinoblastoma, Unilateral Retinoblastoma

Allison Fullenkamp - fulle631@umn.edu
Joseph Neglia, M.D.
NA
STUDY00004765
NCT03932786
See this study on ClinicalTrials.gov

Back